Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C027576 |
4-hydroxy-2-nonenal |
4-hydroxy-2-nonenal results in increased oxidation of ATP8A1 protein | increases oxidation | 15033435
|
D000171 |
Acrolein |
Acrolein results in increased oxidation of ATP8A1 protein | increases oxidation | 15033435
|
D001151 |
Arsenic |
Arsenic results in decreased expression of ATP8A1 mRNA | decreases expression | 19654921
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of ATP8A1 mRNA | increases expression | 15761015
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of ATP8A1 mRNA | increases expression | 20106945
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of ATP8A1 mRNA | affects cotreatment|increases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of ATP8A1 mRNA | increases expression | 19619570
|
D015525 |
Fatty Acids, Omega-3 |
Fatty Acids, Omega-3 results in decreased expression of ATP8A1 mRNA | decreases expression | 16823509
|
D008345 |
Manganese |
Manganese results in decreased expression of ATP8A1 mRNA | decreases expression | 17175027
|
C025340 |
manganese chloride |
manganese chloride results in decreased expression of ATP8A1 mRNA | decreases expression | 17175027
|
C030589 |
methylmercury cysteine |
methylmercury cysteine results in increased expression of ATP8A1 mRNA | increases expression | 19465457
|
D043371 |
Fatty Acids, Omega-6 |
Fatty Acids, Omega-6 results in increased expression of ATP8A1 mRNA | increases expression | 16823509
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ATP8A1 mRNA | affects binding|decreases expression|increases activity | 19710929
|
D011374 |
Progesterone |
Progesterone affects the expression of ATP8A1 mRNA | affects expression | 17251523
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of ATP8A1 mRNA | affects cotreatment|increases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of ATP8A1 mRNA | decreases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ATP8A1 mRNA | increases expression | 19619570
|
D014415 |
Tunicamycin |
Tunicamycin results in decreased expression of ATP8A1 mRNA | decreases expression | 17127020
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.90 | 11752688 14514962 15322242 |
MESH:D055371 |
Acute Lung Injury |
|
Acrolein |
9.40 | 21297076 20525806 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
9.40 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.42 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.42 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.07 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.07 | 16835633 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
5.28 | 17306315 |
MESH:D000544 |
Alzheimer Disease |
|
Acrolein |
3.28 | 15207723 14715435 17570602 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
4.12 | 10965797 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.97 | 11748828 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Manganese |
11.13 | 16910769 |
MESH:D000756 |
Anemia, Sideroblastic |
|
manganese chloride |
11.13 | 16910769 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.87 | 16251483 16835338 18414634 12569548 |
MESH:D001161 |
Arteriosclerosis |
|
Acrolein |
5.05 | 15014928 |
MESH:D050197 |
Atherosclerosis |
|
Acrolein |
7.20 | 16126721 17363696 16037261 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
7.20 | 19371607 12928151 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Fatty Acids, Omega-3 |
9.33 | 18448859 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Fatty Acids, Omega-6 |
9.33 | 18448859 |
MESH:D001321 |
Autistic Disorder |
|
Fatty Acids, Omega-3 |
3.47 | 16920077 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
15.46 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
15.46 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
15.46 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.85 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.78 | 15746008 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.40 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.30 | 15845082 15380490 15665606 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.84 | 16675129 18497071 12948864 17018787 17289903 17261762 19861407 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
1.84 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.84 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.36 | 11589617 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.51 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.82 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.61 | 17687452 15504454 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
4.68 | 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
4.68 | 15073043 15553829 16217749 11135700 14691202 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.68 | 16924424 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.94 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.14 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
2.70 | 15504454 17687452 18922899 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
4.10 | 18640142 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.38 | 18670907 18850075 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
3.47 | 17938729 15738583 19152805 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.33 | 16973168 18022660 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.64 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.64 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.19 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.83 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.83 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.11 | 12621046 15340226 16354765 15668235 8697196 |
MESH:D015179 |
Colorectal Neoplasms |
|
Acrolein |
2.89 | 17597105 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.89 | 20501625 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.08 | 17141729 14669216 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.22 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
2.48 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.48 | 20055451 10048152 15322242 |
MESH:D003556 |
Cystitis |
|
Acrolein |
5.45 | 12161096 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.13 | 15213294 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.44 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.44 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.53 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.54 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.78 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.63 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.63 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.96 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.82 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.00 | 19148513 18566989 11473722 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
9.02 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
9.02 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
2.32 | 12903497 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.03 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
13.24 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
13.24 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
13.24 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.50 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.62 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.62 | 20067830 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.62 | 6392382 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.30 | 16904648 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.27 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Manganese |
3.93 | 17043766 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.66 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.34 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.55 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.47 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.36 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.40 | 19176532 18467677 19772884 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.40 | 12621046 15340226 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.09 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.81 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.11 | 8697196 18606429 15340226 16354765 16959395 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.21 | 20558911 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.48 | 17050553 |
MESH:D006973 |
Hypertension |
|
Arsenic |
8.64 | 11953799 9931084 16076760 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.64 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.64 | 18670907 18850075 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.62 | 16093927 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.44 | 15869954 |
MESH:D007249 |
Inflammation |
|
Fatty Acids, Omega-3 |
8.60 | 17296493 |
MESH:D007249 |
Inflammation |
|
Progesterone |
8.60 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.60 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.26 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.26 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.36 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.50 | 15604871 |
MESH:D007642 |
Keratosis |
|
Arsenic |
5.04 | 16930632 12749816 |
MESH:D007674 |
Kidney Diseases |
|
Acrolein |
10.29 | 12488133 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
10.29 | 8314463 18776723 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
10.29 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.35 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.35 | 15610895 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.84 | 15070760 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.82 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.36 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.45 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.79 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.14 | 17050201 16467208 19850784 16968895 20471514 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
7.84 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
7.84 | 19225113 16112521 17217047 9834237 16966277 17107899 15748426 19035177 16331271 11468182 12018890 17712046 15622746 16330433 15336539 19642359 11161223 17869043 16823087 16891316 12712474 12679006 19075265 17649720 15213294 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.39 | 16882451 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.39 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.39 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.39 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
2.55 | 11134558 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
10.78 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
10.78 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
10.78 | 15890375 16377806 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.78 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
5.86 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.86 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.37 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Acrolein |
4.23 | 11504702 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
3.46 | 19168569 17976673 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
3.46 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.46 | 11884234 19555203 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.12 | 11807958 11408345 17203775 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.12 | 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
13.22 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Manganese |
13.22 | 19453300 16551646 16568477 |
MESH:D008546 |
Melanoma, Experimental |
|
Acrolein |
5.25 | 10803710 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.85 | 16801185 |
MESH:D009069 |
Movement Disorders |
|
Manganese |
5.04 | 16551646 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.12 | 14977855 11468182 15949261 19549372 19417148 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.55 | 16239165 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.73 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.16 | 16882451 16105982 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.15 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
9.08 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
9.08 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.32 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
8.32 | 16411023 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.00 | 16624393 |
MESH:D009369 |
Neoplasms |
|
Acrolein |
5.37 | 17329238 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.37 | 17405874 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.78 | 17289903 |
MESH:D009393 |
Nephritis |
|
Acrolein |
6.35 | 12653641 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.50 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.31 | 19348381 18481113 |
MESH:D009410 |
Nerve Degeneration |
|
Manganese |
4.29 | 16551646 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.59 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.59 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
7.51 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
7.51 | 10525206 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acrolein |
4.53 | 11342003 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.41 | 17056641 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.82 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
11.39 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
11.39 | 16624393 12452020 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
11.39 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
11.39 | 17393432 16525653 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
2.53 | 15580305 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.19 | 19927285 |
MESH:D010300 |
Parkinson Disease |
|
Acrolein |
6.04 | 17690948 |
MESH:D010300 |
Parkinson Disease |
|
Manganese |
6.04 | 11181820 |
MESH:D020734 |
Parkinsonian Disorders |
|
Manganese |
4.50 | 16140633 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.31 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.21 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
5.04 | 6392382 16905509 15371236 |
MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
13.67 | 11550810 |
MESH:D010787 |
Photosensitivity Disorders |
|
Acrolein |
13.67 | 11550810 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.59 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.25 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.24 | 11118676 11896295 11399792 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.91 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.60 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.60 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.60 | 16740699 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
4.04 | 21343184 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
MESH:D051437 |
Renal Insufficiency |
|
Acrolein |
5.05 | 12732208 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.40 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.87 | 18990726 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.86 | 18045962 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.00 | 16646077 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.75 | 6392382 19834688 17453740 17938729 16759981 15952646 16353154 17050553 18709164 17548696 16702368 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
5.75 | 17976673 15504454 17029826 16251483 19538983 17050553 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.75 | 16192470 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.33 | 15862959 16503802 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
1.86 | 17007042 |
MESH:D020521 |
Stroke |
|
Acrolein |
4.58 | 16269634 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.96 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
3.11 | 19014326 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.75 | 19048282 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.01 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
5.31 | 17976673 17306315 18640142 11144890 19429237 19322015 15987713 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
5.31 | 12845720 12973940 20435036 11780464 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.05 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
4.79 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.66 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.31 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.50 | 17120751 |